Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
Today is World Atopic Eczema Day, established to enhance awareness, understanding and management of a skin condition that can severely affect patients’ health and wellbeing.
Ipsos Healthcare, the global healthcare business of Ipsos, has announced the launch of its syndicated Multiple Sclerosis (MS) Patient Community Panel. This latest offer is part of the Ipsos Healthcare Global Patient Centre of Excellence, launched in 2018.
![[Webinar] Real evidence from real experiences: Patient Centric Evidence](/sites/default/files/styles/list_item_image/public/ct/event/2026-03/ipsos-webinar-real-evidence-real-experiences.webp?itok=i_Bx2O-9)
